Johnson & Johnson’s Oral IL-23 Receptor Blocker Shows Promise in Moderate-to-severe Plaque PsO
JNJ-2113, Johnson & Johnson’s oral IL-23 receptor blocker, showed positive results in moderate-to-severe plaque psoriasis, according to the Phase 2b FRONTIER 1 study published in the New England Journal of Medicine. JNJ-2113 is the first and only investigational targeted oral peptide inhibitor designed to block the IL-23 receptor. IL-23 plays a critical role in pathogenic T-cell […]
La Roche-Posay Taps Tennis Pro Jannik Sinner as Anthelios Global Brand Advocate
Italian tennis pro Jannik Sinner is La Roche-Posay’s new global brand advocate. This long-term collaboration aims to address the lack of protection and education around UV rays. leveraging La Roche-Posay’s Anthelios sunscreen collection. Mr. Sinner, who plays tennis outdoors all year long, will help raise awareness about the importance of photoprotection.
Neutrogena Rolls Out Sustainable Hydro Boost Water Gel Refill Pods
Neutrogena is launching its Hydro Boost Water Gel Refillable Jar + Refill Pod Starter Kit. This is the company’s first refillable jar and pod. When the Starter Kit jar runs empty, consumers twist and remove the empty pod and replace with a refill pod, reducing plastic waste by 89% compared to the brand’s refillable jar. “We […]
FDA to Review Biofrontera’s sNDA for Ameluz Dosage Increase
The U.S. Food and Drug Administration (FDA) has issued a “no filing review issues identified” letter regarding Biofrontera’s sNDA (supplementary New Drug Application) which aims to increase the maximally approved dosage from one to three tubes of Ameluz per treatment. The FDA has completed its filing review and will begin its substantive review of Biofrontera’s communication with […]
Diagnosing Skin Disease in Images of Darker Skin: Can AI Help?
When diagnosing skin diseases based solely on images, doctors don’t perform as well when the patient has darker skin, according to a new study from MIT researchers. The study, which included more than 1,000 dermatologists and general practitioners, found that dermatologists accurately characterized about 38% of the images they saw, but only 34% of those that showed […]
Don’t Miss Out: ASA Announces 2024 Grant Opportunities for Dermatology Researchers
The American Skin Association (ASA) announced its 2024 grant opportunities for dermatologists treating skin cancer and other diseases. “ASA is proud to announce that the 2024 grant opportunities to support medical and educational initiatives total nearly $750,000, which is the largest offering to date,” says ASA Chairman Howard P. Milstein in a news release. “For […]
New AAD Acne Guidelines: Cost Shouldn’t Be the Reason Behind Conditional Recommendations
By Julie Harper, MD The pathogenesis of acne is complex and often requires a combination of different topical and/or oral medications to achieve clearance. I regularly devise unique treatment plans for my patients that take into consideration the mechanism of action of the drug, the efficacy, the tolerability, patient preference, and the cost and accessibility to […]
Pediatric Eczema, Eosinophilic Esophagitis Linked
Children and young adults with eczema or allergies who have difficulty swallowing may also have eosinophilic esophagitis, according to a review study in the Canadian Medical Association Journal (CMAJ). In people with eosinophilic esophagitis, the esophageal lining is inflamed, which can cause injury and narrowing of the throat. Although it can affect anyone, the risk is higher in children […]
TDD Industry News and Views: Weekly Updates on Comings, Goings, and Other Happenings in Dermatology
And the Winner Is…Trufacial Trufacial, an at-home skin rejuvenation device, took home the 2024 People’s Choice Award at Octane Aesthetics Tech Forum in Newport Beach, CA. “We are honored to be recognized for the 2024 People’s Choice Award by Octane’s esteemed judges, entrepreneurs and experts in dermatology and plastic surgery,” says Dina El-Sherif, MBA, founder and CEO […]
Multimillion-dollar Malpractice Verdicts Are on the Rise. What Gives?
By Ted Rosen, MD Recent data from TransRe, an international reinsurance company, show that massive multimillion-dollar malpractice verdicts are on the rise and that even average malpractice verdicts are increasing in amount. In fact, the average of 2023 malpractice verdicts far exceeded any other prior year. While New York, Florida, and Illinois were once the leaders […]